Niven Daniel J, Laupland Kevin B, Tabah Alexis, Vesin Aurélien, Rello Jordi, Koulenti Despoina, Dimopoulos George, de Waele Jan, Timsit Jean-Francois
Crit Care. 2013 Dec 10;17(6):R289. doi: 10.1186/cc13153.
Although fever and hypothermia are common abnormal physical signs observed in patients admitted to intensive care units (ICU), little data exist on their optimal management. The objective of this study was to describe contemporary practices and determinants of management of temperature abnormalities among patients admitted to ICUs.
Site leaders of the multi-national EUROBACT study were surveyed regarding diagnosis and management of temperature abnormalities among patients admitted to their ICUs.
Of the 162 ICUs originally included in EUROBACT, responses were received from 139 (86%) centers in 23 countries in Europe (117), South America (8), Asia (5), North America (4), Australia (3) and Africa (2). A total of 117 (84%) respondents reported use of a specific temperature threshold in their ICU to define fever. A total of 14 different discrete levels were reported with a median of 38.2°C (inter-quartile range, IQR, 38.0°C to 38.5°C). The use of thermometers was protocolized in 91 (65%) ICUs and a wide range of methods were reportedly used, with axillary, tympanic and urinary bladder sites as the most common as primary modalities. Only 31 (22%) of respondents indicated that there was a formal written protocol for temperature control among febrile patients in their ICUs. In most or all cases practice was to control temperature, to use acetaminophen, and to perform a full septic workup in febrile patients and that this was usually directed by physician order. While reported practice was to treat nearly all patients with neurological impairment and most patients with acute coronary syndromes and infections, severe sepsis and septic shock, this was not the case for most patients with liver failure and fever.
A wide range of definitions and management practices were reported regarding temperature abnormalities in the critically ill. Documenting temperature abnormality management practices, including variability in clinical care, is important to inform planning of future studies designed to optimize infection and temperature management strategies in the critically ill.
尽管发热和体温过低是重症监护病房(ICU)收治患者中常见的异常体征,但关于其最佳管理的数据却很少。本研究的目的是描述ICU收治患者体温异常管理的当代实践及决定因素。
对多国EUROBACT研究的各中心负责人就其ICU收治患者体温异常的诊断和管理进行了调查。
EUROBACT最初纳入的162个ICU中,来自欧洲(117个)、南美洲(8个)、亚洲(5个)、北美洲(4个)、澳大利亚(3个)和非洲(2个)23个国家的139个中心(86%)进行了回复。共有117名(84%)受访者报告在其ICU中使用特定温度阈值来定义发热。共报告了14个不同的离散水平,中位数为38.2°C(四分位间距,IQR,38.0°C至38.5°C)。91个(65%)ICU对温度计的使用制定了方案,据报道使用了多种方法,其中腋窝、鼓膜和膀胱部位作为最常见的主要测量部位。只有31名(22%)受访者表示其ICU中有针对发热患者体温控制的正式书面方案。在大多数或所有情况下,做法是控制发热患者的体温、使用对乙酰氨基酚并进行全面的脓毒症检查,这通常由医生医嘱指导。虽然报告的做法是治疗几乎所有有神经功能障碍的患者以及大多数患有急性冠状动脉综合征、感染、严重脓毒症和脓毒性休克的患者,但大多数肝功能衰竭伴发热的患者并非如此。
关于危重症患者体温异常的定义和管理实践存在广泛差异。记录体温异常管理实践,包括临床护理的变异性,对于为未来旨在优化危重症患者感染和体温管理策略的研究规划提供信息很重要。